Abingdon Health Plc (AIM:ABDX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 9.00
0.00 (0.00%)
Oct 23, 2026, 9:52 AM BST
Abingdon Health Financials Overview
Financials in millions GBP. Fiscal year is July - June.
Millions GBP. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 10.99 | 10.99 | 8.43 | 6.14 | 4.05 | 2.84 |
Revenue Growth | 14.85% | 30.42% | 37.39% | 51.67% | 42.68% | -75.60% |
Gross Profit Gross Profit Growth | 5.18 | 5.18 | 3.74 | 3.68 | 2.08 | -3.59 |
Operating Income Operating Income Growth | -2.83 | -2.83 | -4.33 | -1.85 | -3.61 | -11.87 |
Net Income Net Income Growth | -2.13 | -2.13 | -3.42 | -1.27 | -3.47 | -21.26 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.00 | -0.01 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Product Sales Product Sales Growth | 0.6 | 0.6 | 0.53 | 0.65 | 0.42 | 0.47 |
Contract Manufacturing Contract Manufacturing Growth | 1.27 | 1.27 | 1.27 | 1.26 | 1.06 | 1.12 |
Contract Development Contract Development Growth | 4.99 | 4.99 | 3.21 | 3.33 | 2.3 | 1.25 |
Regulatory Regulatory Growth | 4.13 | 4.13 | 3.42 | 0.9 | 0.27 | - |
Total Total Growth | 10.99 | 10.99 | 8.43 | 6.14 | 4.05 | 2.84 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 2.87 | 2.87 | 1.92 | 1.44 | 3.24 | 2.4 |
Total Debt Total Debt Growth | 1.34 | 1.34 | 1.03 | 1.05 | 1.02 | 1.28 |
Net Cash (Debt) Net Cash Growth | 1.52 | 1.52 | 0.89 | 0.39 | 2.22 | 1.12 |
Net Cash Growth | -44.76% | 71.24% | 127.62% | -82.36% | 98.48% | -67.92% |
Net Cash Per Share Net Cash Per Share Growth | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -1.61 | -1.61 | -3.18 | -1.66 | 0.91 | -7.74 |
Capital Expenditures CapEx Growth | -0.19 | -0.19 | -0.33 | -0.04 | -0.08 | -0.68 |
Free Cash Flow Free Cash Flow Growth | -1.8 | -1.8 | -3.51 | -1.69 | 0.84 | -8.42 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 47.10% | 47.10% | 44.32% | 59.97% | 51.30% | -126.70% |
Operating Margin | -25.77% | -25.77% | -51.38% | -30.11% | -89.27% | -418.52% |
Pretax Margin | -18.39% | -18.39% | -41.48% | -22.80% | -88.36% | -761.66% |
Profit Margin | -19.36% | -19.36% | -40.52% | -20.72% | -85.76% | -749.98% |
FCF Margin | -16.38% | -16.38% | -41.63% | -27.61% | 20.72% | -297.04% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 24, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
P/FCF Ratio | - | - | - | - | 43.54 | - |
PS Ratio | 3.56 | 4.06 | 3.12 | 5.16 | 9.02 | 11.80 |